Movement disorder emergencies.
For the past 4 years, Dr. Stanley Fahn and I have given a course at the American Academy of Neurology annual meeting on the topic of movement disorder emergencies. The purpose of this review article is to summarize the topic and to present it to readers of this journal. The text of this article has appeared in nearly the same form as the Academy syllabus accompanying our course. It is being presented here so that readers of the journal may review the material.
Frucht
Steven J
SJ
Department of Neurology, Columbia University Medical Center, 710 West 168th Street, New York, NY 10032, USA. sf216@columbia.edu
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000009:adverse effects; D002819:Chorea / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D004421:Dystonia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D004630:Emergencies; D006801:Humans; D009069:Movement Disorders / Q000175:diagnosis* / Q000503:physiopathology*; D009207:Myoclonus / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D020734:Parkinsonian Disorders / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D020323:Tics / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology
D014150:Antipsychotic Agents